Skip to main content

CJC Ipamorelin Synergy

Meaning

CJC Ipamorelin Synergy is the combined clinical application of CJC-1295 and Ipamorelin, two synthetic peptides, to achieve a synergistic and sustained release of endogenous Growth Hormone (GH) from the pituitary gland. CJC-1295, a Growth Hormone-Releasing Hormone (GHRH) analog, provides a long-acting signal, while Ipamorelin, a Growth Hormone Secretagogue (GHRP), offers a potent, pulsatile stimulus. This specific combination is designed to mimic the body’s natural, physiological pattern of GH secretion, maximizing therapeutic benefit while minimizing negative feedback on the somatotropic axis.